Jefferies Raises Price Target on Zimmer Biomet Holdings (ZBH) Following 2Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Stay long AI-capex winners into the peak, Stifel says despite bubble fears
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
UBS Raises Price Target on Zimmer Biomet Holdings (ZBH) Following 2Q Earnings Report
August 2, 2016 9:18 AM EDTUBS reiterated a Neutral rating on Zimmer Biomet (NYSE: ZBH), and raised the price target to $132.00 (from $117.00), following the company's 2Q earnings report.
Analyst Matt Miksic commented, "WW sales growth improved in Q2 for most business lines, partially driven by extra selling days (+1.9% WW), and Zimmer Biomet narrowed its gap in... More
Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 5c; Boosts FY16 Outlook
July 28, 2016 7:39 AM EDTZimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $2.02, $0.05 better than the analyst estimate of $1.97. Revenue for the quarter came in at $1.93 billion versus the consensus estimate of $1.9 billion.
GUIDANCE:
Zimmer Biomet Holdings sees FY2016 EPS of $7.90-$8.00, versus prior... More
Trading Radar for 7/28: Alphabet (GOOG), Amazon (AMZN), Ford (F), Baidu (BIDU), MasterCard (MA) Report
July 27, 2016 2:49 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EDT
Earnings:
ACI Worldwide, Inc. (Nasdaq: ACIW) - consensus loss $0.04
ARIAD Pharma (Nasdaq: ARIA) - consensus loss $0.11
Acorda Therapeutics (Nasdaq: ACOR) - consensus EPS $0.18
Agenus (Nasdaq: AGEN) - consensus... More
